Literature DB >> 13584873

Serum transaminase: its clinical use in diagnosis and prognosis.

R BRUCE, J K TODD, L LEDUNE.   

Abstract

Keywords:  MYOCARDIAL INFARCT/blood in; TRANSAMINASES/in blood

Mesh：

Substances：

Year:  1958        PMID： 13584873      PMCID： PMC2026700          DOI： 10.1136/bmj.2.5105.1125

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  10 in total

1.  Serum transaminase as a measure of myocardial necrosis.

Authors:  D STEINBERG; B H OSTROW
Journal:  Proc Soc Exp Biol Med       Date:  1955-05

2.  The significance of the serum glutamic oxalacetic transaminase activity following acute myocardial infarction.

Authors:  J S LADUE; F WROBLEWSKI
Journal:  Circulation       Date:  1955-06       Impact factor: 29.690

3.  Evaluation of the serum glutamic oxalacetic aminopherase (transaminase) test; its use in diagnosis of acute myocardial infarction.

Authors:  J L DENNEY; C B MCAULEY; H E MARTIN; A G WARE; M SEGALOVE
Journal:  J Am Med Assoc       Date:  1956-06-16

4.  Transaminase in coronary artery disease.

Authors:  J T RATNER; H J SACKS
Journal:  Can Med Assoc J       Date:  1957-05-01       Impact factor: 8.262

5.  Serum transaminase determinations as a diagnostic aid in myocardial infarction.

Authors:  R SHABETAI; A IGLAUER; D M ANDERSON
Journal:  Br Med J       Date:  1957-03-09

6.  Routine methods for the estimation of serum transaminase.

Authors:  J KING
Journal:  J Med Lab Technol       Date:  1958-01

7.  Serum transaminase levels in experimental pulmonary infarction.

Authors:  C M AGRESS; H F GLASSNER; H I JACOBS
Journal:  Circ Res       Date:  1956-03       Impact factor: 17.367

8.  Serum transaminase activity; observations in a large group of patients.

Authors:  M CHINSKY; G L SHMAGRANOFF; S SHERRY
Journal:  J Lab Clin Med       Date:  1956-01

9.  Serum glutamic oxalacetic aminopherase (transaminase) in hepatitis.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  J Am Med Assoc       Date:  1956-03-31

10.  Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction.

Authors:  J S LADUE; F WROBLEWSKI; A KARMEN
Journal:  Science       Date:  1954-09-24       Impact factor: 47.728
  10 in total
  6 in total

1.  Creatine kinase MM TaqI and methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms influence exercise-induced C-reactive protein levels.

Authors:  Ana Luisa Miranda-Vilela; Arthur K Akimoto; Graciana S Lordelo; Luiz C S Pereira; Cesar K Grisolia; Maria de Nazaré Klautau-Guimarães
Journal:  Eur J Appl Physiol       Date:  2011-04-23       Impact factor: 3.078

2.  SERUM TRANSAMINASE ACTIVITY IN STATUS ASTHMATICUS.

Authors:  A H EL-SHABOURY; A J THOMAS; D A WILLIAMS
Journal:  Br Med J       Date:  1964-05-09

3.  THE PLACE OF TRANSAMINASE IN THE DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION.

Authors:  R BRUCE
Journal:  J Coll Gen Pract       Date:  1963-11

4.  SERUM LACTIC DEHYDROGENASE ESTIMATIONS IN MYOCARDIAL INFARCTION.

Authors:  T W Stewart; F G Warburton
Journal:  Br Heart J       Date:  1961-05

5.  Creatine kinase MM TaqI and methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms influence exercise-induced C-reactive protein levels.

Authors:  Ana Luisa Miranda-Vilela; Arthur K Akimoto; Graciana S Lordelo; Luiz C S Pereira; Cesar K Grisolia; Maria de Nazaré Klautau-Guimarães
Journal:  Eur J Appl Physiol       Date:  2011-06-26       Impact factor: 3.078

6.  The influence of female mice age on biodistribution and biocompatibility of citrate-coated magnetic nanoparticles.

Authors:  Willie O Pinheiro; Maria L Fascineli; Gabriel R Farias; Frederico H Horst; Laise Rodrigues de Andrade; Luis Henrique Corrêa; Kelly Grace Magalhães; Marcelo Henrique Sousa; Marcos C de Almeida; Ricardo B Azevedo; Zulmira G M Lacava
Journal:  Int J Nanomedicine       Date:  2019-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.